Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-14

Clinical Trial Update: The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating the innate central nervous system immune response to an experimental immune challenge in people with fibromyalgia has completed, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Fibromyalgia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-04-14